# DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding

> **NCT01148420** · PHASE4 · COMPLETED · sponsor: **Women's Health Care Clinic, Torrance, California** · enrollment: 48 (actual)

## Conditions studied

- Dysfunctional Uterine Bleeding

## Interventions

- **DRUG:** Medroxyprogesterone 17-Acetate
- **DRUG:** medroxyprogesterone acetate

## Key facts

- **NCT ID:** NCT01148420
- **Lead sponsor:** Women's Health Care Clinic, Torrance, California
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-10
- **Final completion:** 2012-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148420, "DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01148420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*